Company intelligence / Profile preview
Septodont
Saint-Maur-des-Fossés, Franceseptodont.com ↗
- Ownership
- Private
- Employees
- ~2500
- Development stage
- Commercial
01
Overview
Septodont has a long-standing track record of innovation in dental pharmaceuticals and medical devices. It leads the global market in local dental anesthetics with over half a billion cartridges produced annually. Its portfolio includes commercialized injectable anesthetics, topical gels, needles/syringes, bioceramic root canal sealers, dentin substitutes like Biodentine/Biodentine XP, and oral hydrogel wound dressings. The company continues to expand through R&D and strategic investments/partnerships.
- Therapeutic areas
- Other
- Modalities
- Small moleculeBiologicDeviceHydrogel-based drug delivery therapy
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
Investment partnership with Balanced Pharma for next-generation dental anesthetic solutions
Beyond the preview
Go deeper on Septodont.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Septodont.